Posted inResearch
Canadian $5M accelerated clinical trial program cuts start-up to 45 days
A newly launched $5 million clinical trial program allows clinical trial sponsors to start trials in as little as 45…
Posted inBiotechnology
Enanta sheds staffers as key antiviral, immunology readouts loom
As antiviral specialist Enanta Pharmaceuticals endeavors to expand into immunology, the company has decided to lay off 37 employees, Fierce…
Posted inBiotechnology
Highlight Therapeutics illuminates positive ph. 2 topline data in high-risk skin cancer
Highlight Therapeutics touted positive topline results in patients with localized high-risk head and neck basal cell carcinoma (BCC). The phase…
Posted inBiotechnology
uniQure stock crashes as Huntington’s gene therapy data weaken
uniQure’s Huntington’s disease gene therapy has failed to significantly slow disease progression after 48 months, sending the biotech’s stock down 41%…
Posted inBiotechnology
Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui
Novo’s ongoing attempts to rejuvenate its pipeline have seen the Big Pharma turn to one of the most in-demand drug…
Posted inBiotechnology
AstraZeneca scales Summit’s PD-1xVEGF strategy with $2B investment to fuel ADC combos
AstraZeneca is investing $2 billion in Summit Therapeutics to accelerate the development of PD-1xVEGF bispecific ivonescimab in combination with antibody-drug conjugates…
Posted inGenetics
AI Tool Helps Link BRSK1 Variants to Neurodevelopmental Disorder
For many families affected by rare genetic conditions, genomic testing does not immediately deliver an answer. Now, researchers have combined…
Posted inGenetics
Antibody Blocks T Cell Infiltration and Limits Neurodegeneration in Alzheimer’s Mice
Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to reducing neurodegeneration in…
Posted inBiotechnology
ai3Bio emerging from stealth to ‘take the gun out of the hands of the immune system’
ai3Bio has emerged from stealth with $48 million in funding and a buzzing platform for targeting T cells in autoimmune…
Posted inGenetics
Scientists Observe Enzymes Breaking Down DNA in Real Time
The Kanazawa University experiments revealed how the physical organization of DNA can protect it from degradation. [Just_Super/Getty Images] Researchers at…